Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
Conditions:   Ependymoma;   Medulloblastoma;   Glioblastoma;   Primitive Neuroectodermal Tumor (PNET) Interventions:   Drug: Ibrutinib;   Drug: Indoximod;   Drug: Cyclophosphamide;   Drug: Etoposide Sponsors:   Theodore S. Johnson;   Augusta University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2021 Category: Research Source Type: clinical trials